Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Deloitte
Cipla
Cantor Fitzgerald
Julphar
Cerilliant
Fish and Richardson
Mallinckrodt
UBS

Generated: June 19, 2018

DrugPatentWatch Database Preview

TICAR Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Ticar patents expire, and when can generic versions of Ticar launch?

Ticar is a drug marketed by Glaxosmithkline and is included in two NDAs.

The generic ingredient in TICAR is ticarcillin disodium. There are five drug master file entries for this compound. Additional details are available on the ticarcillin disodium profile page.
Summary for TICAR
Drug patent expirations by year for TICAR
Medical Subject Heading (MeSH) Categories for TICAR
Synonyms for TICAR
(2S,5R,6R)-6-[[(2R)-3-hydroxy-3-oxo-2-(3-thienyl)propanoyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-[[(2R)-CARBOXY-3-THIENYLACETYL]AMINO]-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID DISODIUM SALT
29457-07-6
29457-07-6,34787-01-4(freebase)
34807-28-8
4697-14-7
74682-62-5
A822398
A827122
AC1LAKYM
Aerugipen
AK239183
AKOS027276160
API0004413
BIT0186
BRL 2288
C-22212
C14021
CAS-4697-14-7
CC-35060
CHEBI:35017
CHEMBL1200855
D02241
Disodium (2S-(2alpha,5alpha,6beta(S*)))-6-(carboxylato-3-thienylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate
disodium (2S,5R,6R)-3,3-dimethyl-6-[[(2R)-3-oxidanidyl-3-oxidanylidene-2-thiophen-3-yl-propanoyl]amino]-7-oxidanylidene-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
disodium (2S,5R,6R)-3,3-dimethyl-6-[[(2R)-3-oxido-3-oxo-2-thiophen-3-ylpropanoyl]amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
disodium (2S,5R,6R)-6-[[(2R)-2-carboxylato-1-oxo-2-(3-thiophenyl)ethyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
disodium (2S,5R,6R)-6-{[(2R)-2-carboxylato-2-thiophen-3-ylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
disodium 6beta-{[(2R)-2-carboxylato-2-thiophen-3-ylacetyl]amino}-2,2-dimethylpenam-3alpha-carboxylate
Disodium Ticarcillin
DSSTox_CID_25561
DSSTox_GSID_45561
DSSTox_RID_80958
EINECS 249-642-5
G8TVV6DSYG
HE337202
HMS1571E16
MFCD07787410
MolPort-003-959-756
Monapen
N-(2-Carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-3-thiophenemalonamic acid disodium salt
NCGC00017046-01
SCHEMBL41224
Ticar (TN)
TICARCILLIN DISODIUM
Ticarcillin disodium (USP)
Ticarcillin disodium salt
Ticarcillin Disodium Salt (Contain 10% Methanol)
Ticarcillin disodium salt, >=95%
ticarcillin sodium
Ticarcillin sodium (JAN)
Ticarcillinsodium
Ticarpen
Tox21_110756
UNII-G8TVV6DSYG
ZX-AFC000251

US Patents and Regulatory Information for TICAR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline TICAR ticarcillin disodium INJECTABLE;INJECTION 050497-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline TICAR ticarcillin disodium INJECTABLE;INJECTION 050497-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline TICAR ticarcillin disodium INJECTABLE;INJECTION 062690-001 Dec 19, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline TICAR ticarcillin disodium INJECTABLE;INJECTION 050497-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Citi
Colorcon
Healthtrust
Johnson and Johnson
Accenture
Julphar
Express Scripts
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.